Visceral obesity is associated with high levels of serum squalene

Obesity (Silver Spring). 2006 Jul;14(7):1155-63. doi: 10.1038/oby.2006.132.

Abstract

Objective: To investigate the impact of visceral obesity on cholesterol metabolism in normoglycemic offspring of patients with type 2 diabetes.

Research methods and procedures: The proportion of intra-abdominal fat (IAF) was measured by abdominal computer tomography, and serum cholesterol synthesis and absorption markers were determined by gas-liquid chromatography in 109 normoglycemic offspring of patients with type 2 diabetes. Insulin action was measured with the hyperinsulinemic euglycemic clamp. The gene encoding squalene synthase (farnesyl-diphosphate farnesyltransferase 1) was screened with the single-strand conformation polymorphism analysis and direct sequencing.

Results: Cholesterol synthesis markers correlated positively with IAF (r = 0.213 to 0.309, p < or = 0.027) and negatively with the rates of insulin-stimulated whole-body glucose uptake (r = -0.372 to -0.248, p < or = 0.010). However, serum squalene, the first measured precursor of cholesterol synthesis, showed a positive correlation with IAF (r = 0.309, p = 0.001) without any association with subcutaneous fat or insulin sensitivity. Variation in the farnesyl-diphosphate farnesyltransferase 1 gene did not explain elevated serum squalene levels in viscerally obese subjects. From the cholesterol absorption markers, cholestanol was associated negatively with IAF and positively with whole-body glucose uptake (p < 0.05).

Discussion: High serum squalene levels are associated with visceral obesity but not with subcutaneous obesity. Whether this finding is causally connected to visceral obesity remains to be established.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / analysis
  • Body Composition / physiology
  • Cholesterol / biosynthesis
  • Cholesterol / metabolism*
  • Diabetes Mellitus, Type 2 / metabolism
  • Farnesyl-Diphosphate Farnesyltransferase / genetics*
  • Female
  • Glucose Clamp Technique
  • Humans
  • Insulin / metabolism*
  • Intestinal Absorption
  • Intra-Abdominal Fat / metabolism*
  • Male
  • Obesity / blood
  • Obesity / etiology*
  • Obesity / metabolism
  • Polymorphism, Single-Stranded Conformational
  • Squalene / blood*

Substances

  • Biomarkers
  • Insulin
  • Squalene
  • Cholesterol
  • Farnesyl-Diphosphate Farnesyltransferase